NCT00393107View on ClinicalTrials.gov

Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2000

Study Completion Date

August 31, 2006

Conditions
Follicular Lymphoma
Interventions
DRUG

rituximab

DRUG

rituximab,fludarabine, cyclophosphamide

Trial Locations (9)

10100

Ospedale Molinette, Torino

20100

Ospedale Maggiore di Milano, Milan

29100

Ospedale di Piacenza, Piacenza

42100

Ospedale S. Maria Nuova, Reggio Emilia

52100

Ospedale di Arezzo, Arezzo

56100

Ospedale di Pisa, Pisa

89100

Ospedale di Pescara, Pescara

Ospedale di Reggio Calabria, Reggio Calabria

06110

Ospedale Monteluce, Perugia

All Listed Sponsors
lead

Gruppo Italiano Studio Linfomi

OTHER

NCT00393107 - Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab | Biotech Hunter | Biotech Hunter